Boyi Biotech

Boyi Biotech, a prominent biological microspheres developer headquartered in Changzhou, has reportedly secured more than RMB100 million in a Series A financing round. The round was led by JOLMO, with additional investments from Bondshine Capital, Wei Chi Equity Fund, and Hua Guoping, the founder of Jiangsu Hualan New Pharmaceutical Material…